Report published August 25, 2026
Melrose (MRON.L): Garden Grove Overhang Moving Towards Resolution – Goldman Sachs Research
Source and citation context
- Issuer
- Goldman Sachs
- Report date
- August 25, 2026
- Analysis as of
- August 24, 2026
Authors / editors: Sam Burgess, Jubril Moronfolu, Milind Sikchi
Finvaulta summarizes Goldman Sachs's analysis. Attribute opinions, forecasts, time-sensitive values, and chronology to the issuer and report date; do not treat this page as an independent verification or a current market-data source.
Melrose has announced an up to US$100mn claims programme and a planned September 28 resumption of operations at Garden Grove following the closure of a criminal probe with no charges. Goldman Sachs reiterates a Buy rating with a 700p price target.
Key Takeaways
- 1.Melrose announced a claims programme of up to US$100mn for eligible residents and businesses following the May evacuation order at Garden Grove.
- 2.The Orange County District Attorney's Office has concluded its investigation with no criminal charges, and manufacturing operations are targeted to resume on 28 September 2026.
- 3.While the US$100mn cost may affect near-term cash flow, it represents only a low-single-digit percentage of equity value, supporting narrowing of the valuation discount.
Table of Contents
- What has Melrose announced today?
- What does this mean for operations?
- Has the Garden Grove overhang now been resolved?
- How significant is the US$100mn?
- What next?
- Valuation & Key Risks
- Disclosure Appendix
Report data
MRON.L Valuation and GS Forecast Table — as of August 24, 2026.
| Metric | Estimate | Context |
|---|---|---|
| 12-Month Price Target | 700 pence | DCF-derived 12-month target price for Melrose |
| Current Share Price | 462 pence | Closing price as of 24 Aug 2026 close |
| Implied Upside | 51.5% | Upside to 12-month price target |
| Garden Grove Claims Programme Cap | 100 USD mn | Claims programme for eligible residents and businesses |
| FY26E Free Cash Flow | 116 GBP mn | GS forecast for FY26 free cash flow |
Document Preview
Access the Full Report
Get unlimited access to institutional research reports. Create an account to get started.
Authors / Editors
Reported Data Context
- 12-Month Price Target: 700 pence (12 months) · Source: Goldman Sachs Research
- Current Share Price: 462 pence (2026-08-24) · Source: FactSet
- Implied Upside: 51.5 % (12 months) · Source: Goldman Sachs Research
- Garden Grove Claims Programme Cap: 100 USD mn (FY2026) · Source: Company data
- FY26E Free Cash Flow: 116 GBP mn (FY2026E) · Source: Goldman Sachs Research
Securities
Themes
Regions
Browse More
Related Reports
European Week Ahead
September 14, 2026
BoE Preview: Holding in September, Hiking in November
September 14, 2026
Asia Leaders Conference Takeaways: TECO: Modular Data Center in Expansion, Driving Deployment and Efficiency
September 14, 2026
China: Market Expectations for the Upcoming Trump-Xi Meeting: Signals from Our Investor Survey
September 14, 2026
China: What Do Local Clients Think About the Economy?
September 14, 2026